Evidence map›Paper›PMID 35207423›Full record

ArticleLife (Basel, Switzerland)2022

Study of the Anticancer Potential of Plant Extracts Using Liver Tumor Microphysiological System.

Hafiz Muhammad Umer Farooqi, Anupamma Sammantasinghar, Farzana Kausar, Muhammad Awais Farooqi, Abdul Rahim Chethikkattuveli Salih, Kinam Hyun, Jong-Hwan Lim, Atif Ali Khan Khalil, Abdul Samad Mumtaz, Kyung Hyun Choi

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Anticancer activity ofHeliyon · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Hafiz Muhammad Umer FarooqiDepartment of Mechatronics Engineering, Jeju National University, Jeju-si 63243, Korea.ORCID 0000-0002-1735-5911
Anupamma SammantasingharDepartment of Mechatronics Engineering, Jeju National University, Jeju-si 63243, Korea.
Farzana KausarDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.
Muhammad Awais FarooqiDepartment of Mechatronics Engineering, Jeju National University, Jeju-si 63243, Korea.
Abdul Rahim Chethikkattuveli SalihDepartment of Mechatronics Engineering, Jeju National University, Jeju-si 63243, Korea.
Kinam HyunDepartment of Mechatronics Engineering, Jeju National University, Jeju-si 63243, Korea.
Jong-Hwan LimDepartment of Mechatronics Engineering, Jeju National University, Jeju-si 63243, Korea.
Atif Ali Khan KhalilDepartment of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan.
Abdul Samad MumtazDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.ORCID 0000-0002-7034-9203
Kyung Hyun ChoiDepartment of Mechatronics Engineering, Jeju National University, Jeju-si 63243, Korea.ORCID 0000-0002-4503-2458
Jeju National University · KRQuaid-i-Azam University · PKNational University of Medical Sciences · PKPakistan Nuclear Regulatory Authority · PK

Funding

Korea Institute for Advancement of Technology P0006848Ministry of Trade, Industry and Energy 2021
6 · The paper itself

Abstract

backgroundPlants have been considered a vital source of modern pharmaceutics since the paleolithic age. Contemporary chemotherapeutic drugs for cancer therapy are chemical entities sourced from plants. However, synthetic drugs or their derivatives come with severe to moderate side effects for human health. Hence, the quest to explore and discover plant-based novel anticancer drugs is ongoing. Anticancer activities are the primary method to estimate the potential and efficacy of an extract or compound for drug discovery. However, traditional in vitro anticancer activity assays often show poor efficacy due to the lack of in-vivo-like cellular environment. In comparison, the animal-based in vivo assays lack human genetic makeup and have ethical concerns.

aimThis study aimed to overcome the limitations of traditional cell-culture-based anticancer assays and find the most suitable assay for anticancer activity of plant extracts. We first reported utilizing a liver tumor microphysiological system in the anticancer effect assessment of plant extracts. METHODOLOGY: Methanolic extracts of

resultsThe study demonstrated the superiority of the TEER sensor-based liver tumor MPS by its better anticancer activity based on cell viability and biomarker analysis compared to the traditional in vitro cell culture model. The anticancer effects of the plant extracts were successfully observed in real time, and methanolic extracts of

conclusionOur results show that the liver tumor microphysiological system could be a better platform for plant-based anticancer activity assessment than traditional cell culture models.

Indexed as

Acer cappadocicum Gledanticancer activityliver tumor microphysiological systemplant extractstransepithelial electrical resistance sensor

Identifiers

PMID35207423
PMCPMC8880716
OpenAlexW4206688971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.